Anti‐IFI16 antibodies in scleroderma are associated with digital gangrene

Conclusion: Anti‐IFI16 antibodies are associated with digital gangrene in scleroderma. Longitudinal prospective studies exploring anti‐IFI16 antibodies as a disease biomarker, and biological studies investigating the pathogenicity of these antibodies, are warranted. This article is protected by copyright. All rights reserved.

Source: Arthritis and Rheumatism - December 29, 2015 Category: Rheumatology Authors: Zsuzsanna H. McMahan, Ami A. Shah, Dhananjay Vaidya, Fredrick M. Wigley, Antony Rosen, Livia Casciola‐Rosen Tags: Full Length Source Type: research